VITAMIN

VITAMIN was reported 93339 times

VITAMIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HOLT-ORAM SYNDROME 2 0.2000
1 RADIOULNAR SYNOSTOSIS 2 0.2000
2 RETROVIRAL INFECTION 2 0.0571
3 ATRIAL HYPERTROPHY 2 0.0222
4 ORAL PUSTULE 2 0.0086
5 APPLICATION SITE ODOUR 1 0.0069
6 ANAL INJURY 1 0.0058
7 CONGENITAL MUSCULOSKELETAL ANOMALY 2 0.0045
8 METAPLASIA 2 0.0042
9 ANORECTAL OPERATION 1 0.0042
10 PRODUCT DIFFICULT TO SWALLOW 4 0.0039
11 TRANSMISSION OF AN INFECTIOUS AGENT VIA A MEDICINAL PRODUCT 3 0.0035
12 HYPERPLASIA 3 0.0033
13 PALATAL DISORDER 2 0.0033
14 INHALATION THERAPY 2 0.0032
15 GASTROINTESTINAL MUCOSAL DISORDER 2 0.0031
16 SEMEN VOLUME DECREASED 3 0.0030
17 TONGUE DRY 4 0.0029
18 PRODUCT COATING ISSUE 3 0.0029
19 CONGENITAL HAND MALFORMATION 2 0.0029
20 ACCOMMODATION DISORDER 2 0.0027
21 AMINO ACID LEVEL INCREASED 2 0.0027
22 ADENOIDAL HYPERTROPHY 1 0.0026
23 CHEMICAL BURN 3 0.0026
24 MACROCYTOSIS 3 0.0026
25 RESORPTION BONE INCREASED 2 0.0024
26 HELICOBACTER GASTRITIS 3 0.0024
27 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 1 0.0024
28 TWIN PREGNANCY 2 0.0024
29 ALVEOLAR OSTEITIS 1 0.0024
30 NOCTURNAL DYSPNOEA 3 0.0024
31 ANAL SPHINCTER ATONY 1 0.0023
32 IMMUNE RECONSTITUTION SYNDROME 3 0.0023
33 TONGUE PRURITUS 2 0.0023
34 CLEFT LIP 2 0.0023
35 CERUMEN IMPACTION 2 0.0022
36 CULTURE URINE POSITIVE 3 0.0021
37 BLOOD LACTIC ACID INCREASED 11 0.0021
38 CHEMICAL BURN OF SKIN 5 0.0020
39 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2 0.0019
40 WRONG PATIENT RECEIVED MEDICATION 5 0.0018
41 AMNIOTIC FLUID VOLUME DECREASED 1 0.0018
42 THERAPEUTIC RESPONSE DELAYED 5 0.0018
43 PULMONARY GRANULOMA 2 0.0018
44 BREAST DISCHARGE 3 0.0017
45 REFLUX GASTRITIS 2 0.0017
46 CEREBRAL ARTERY EMBOLISM 2 0.0016
47 ESSENTIAL HYPERTENSION 3 0.0016
48 EJECTION FRACTION ABNORMAL 2 0.0016
49 BLOOD UREA DECREASED 2 0.0016
50 MALLORY-WEISS SYNDROME 2 0.0016
51 ANOXIC ENCEPHALOPATHY 1 0.0016
52 AORTIC ARTERIOSCLEROSIS 4 0.0016
53 APPLICATION SITE EROSION 2 0.0016
54 CALCIUM DEFICIENCY 2 0.0015
55 FOREIGN BODY IN RESPIRATORY TRACT 2 0.0015
56 EXTRADURAL HAEMATOMA 2 0.0015
57 IMPLANTABLE DEFIBRILLATOR INSERTION 2 0.0015
58 FOREIGN BODY 6 0.0015
59 ANION GAP INCREASED 2 0.0015
60 CANDIDIASIS 6 0.0015
61 PREMENSTRUAL SYNDROME 2 0.0015
62 APPLICATION SITE INFLAMMATION 2 0.0014
63 ANAEMIA MACROCYTIC 3 0.0014
64 GENITAL RASH 2 0.0014
65 APRAXIA 2 0.0013
66 CALCINOSIS 3 0.0013
67 PHARYNGOLARYNGEAL PAIN 7 0.0013
68 CLAVICLE FRACTURE 5 0.0013
69 NAIL DISCOLOURATION 5 0.0013
70 DRUG EFFECT INCREASED 4 0.0013
71 HISTOPLASMOSIS DISSEMINATED 2 0.0013
72 BRONCHITIS CHRONIC 3 0.0012
73 OROPHARYNGEAL BLISTERING 2 0.0012
74 PATHOLOGICAL GAMBLING 2 0.0012
75 MITRAL VALVE PROLAPSE 2 0.0012
76 SLEEP TALKING 2 0.0012
77 CROHN'S DISEASE 8 0.0012
78 INCORRECT STORAGE OF DRUG 2 0.0012
79 MASTECTOMY 2 0.0011
80 HANGOVER 4 0.0011
81 DRUG SCREEN NEGATIVE 2 0.0011
82 TEMPOROMANDIBULAR JOINT SYNDROME 3 0.0011
83 OPHTHALMIC HERPES ZOSTER 2 0.0011
84 ANAEMIA OF CHRONIC DISEASE 1 0.0011
85 NASAL OEDEMA 2 0.0011
86 UTERINE SPASM 2 0.0011
87 LOBAR PNEUMONIA 2 0.0011
88 BLOOD CHOLESTEROL DECREASED 2 0.0011
89 EJACULATION DISORDER 3 0.0011
90 VISUAL DISTURBANCE 6 0.0010
91 AGITATION NEONATAL 1 0.0010
92 ADRENAL DISORDER 2 0.0010
93 ANTINUCLEAR ANTIBODY INCREASED 1 0.0010
94 PHARMACEUTICAL PRODUCT COMPLAINT 27 0.0010
95 CLEFT PALATE 2 0.0010
96 APPLICATION SITE BRUISE 1 0.0010
97 DRUG DELIVERY SYSTEM ISSUE 2 0.0010
98 ANTISOCIAL BEHAVIOUR 1 0.0010
99 REBOUND ACID HYPERSECRETION 3 0.0010
100 CHEST X-RAY ABNORMAL 3 0.0010
101 STOMACH DISCOMFORT 5 0.0010
102 ATRIAL TACHYCARDIA 2 0.0010
103 STAPHYLOCOCCUS TEST POSITIVE 2 0.0009
104 HEPATIC NEOPLASM MALIGNANT 2 0.0009
105 BREAST ENLARGEMENT 3 0.0009
106 TONGUE DISCOLOURATION 4 0.0009
107 INTENTIONAL DEVICE MISUSE 4 0.0009
108 FAECES PALE 2 0.0009
109 TONGUE BLISTERING 2 0.0009
110 HAIR GROWTH ABNORMAL 6 0.0009
111 IRON DEFICIENCY ANAEMIA 8 0.0009
112 NEPHROGENIC ANAEMIA 4 0.0009
113 SPINAL COLUMN STENOSIS 4 0.0008
114 MYOPIA 2 0.0008
115 URINE FLOW DECREASED 2 0.0008
116 ORAL INTAKE REDUCED 2 0.0008
117 RECTAL DISCHARGE 3 0.0008
118 RETINAL TEAR 2 0.0008
119 CARTILAGE INJURY 2 0.0008
120 TENDON INJURY 3 0.0008
121 INFREQUENT BOWEL MOVEMENTS 2 0.0008
122 WRONG TECHNIQUE IN DRUG USAGE PROCESS 29 0.0008
123 HYPERPARATHYROIDISM SECONDARY 2 0.0008
124 EXCORIATION 2 0.0008
125 HOSTILITY 2 0.0008
126 COMMUNICATION DISORDER 3 0.0008
127 LACTOSE INTOLERANCE 2 0.0008
128 BLOOD CHLORIDE DECREASED 2 0.0008
129 ERUCTATION 15 0.0008
130 LIPOMA 2 0.0008
131 SKIN BURNING SENSATION 55 0.0008
132 ACNE 58 0.0008
133 PREGNANCY ON ORAL CONTRACEPTIVE 2 0.0008
134 PRODUCT FORMULATION ISSUE 5 0.0008
135 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
136 GASTROINTESTINAL STROMAL TUMOUR 2 0.0008
137 HYPERLACTACIDAEMIA 2 0.0007
138 PRODUCT SIZE ISSUE 4 0.0007
139 SHOULDER ARTHROPLASTY 2 0.0007
140 INTERNATIONAL NORMALISED RATIO DECREASED 3 0.0007
141 ABDOMINAL RIGIDITY 2 0.0007
142 ANORGASMIA 2 0.0007
143 ABNORMAL LOSS OF WEIGHT 5 0.0007
144 AGORAPHOBIA 1 0.0007
145 TENOSYNOVITIS 2 0.0007
146 FORMICATION 5 0.0007
147 APHONIA 10 0.0007
148 SELF-INJURIOUS IDEATION 3 0.0007
149 SLEEP TERROR 3 0.0007
150 ANTICONVULSANT DRUG LEVEL DECREASED 1 0.0007
151 LUNG NEOPLASM 3 0.0007
152 ROTATOR CUFF SYNDROME 9 0.0007
153 ABNORMAL SENSATION IN EYE 3 0.0007
154 PHARYNGEAL DISORDER 2 0.0007
155 MONOPLEGIA 3 0.0007
156 MELANOCYTIC NAEVUS 3 0.0007
157 HYPERTRIGLYCERIDAEMIA 4 0.0007
158 FEELING DRUNK 5 0.0007
159 HEARING IMPAIRED 4 0.0007
160 BONE MARROW DISORDER 2 0.0007
161 BODY HEIGHT DECREASED 7 0.0007
162 TENDON RUPTURE 8 0.0006
163 NASAL DRYNESS 4 0.0006
164 INVESTIGATION 2 0.0006
165 ARTERIOSCLEROSIS 6 0.0006
166 NON-CARDIAC CHEST PAIN 2 0.0006
167 PNEUMONIA VIRAL 2 0.0006
168 FAECAL INCONTINENCE 3 0.0006
169 ANALGESIC DRUG LEVEL INCREASED 1 0.0006
170 ANOREXIA 8 0.0006
171 AORTIC VALVE DISEASE 1 0.0006
172 ANTICONVULSANT DRUG LEVEL INCREASED 1 0.0006
173 SCAB 7 0.0006
174 NEPHRITIS 2 0.0006
175 HAIR TEXTURE ABNORMAL 8 0.0006
176 PERITONITIS BACTERIAL 6 0.0006
177 PAIN OF SKIN 16 0.0006
178 CORONARY ARTERIAL STENT INSERTION 3 0.0006
179 SKIN IRRITATION 27 0.0006
180 DRUG DELIVERY SYSTEM MALFUNCTION 3 0.0006
181 WEIGHT LOSS POOR 3 0.0006
182 MICTURITION DISORDER 2 0.0006
183 POLYMENORRHOEA 2 0.0006
184 FOOD CRAVING 3 0.0006
185 HEART DISEASE CONGENITAL 2 0.0006
186 HAEMORRHAGIC DIATHESIS 2 0.0006
187 AORTIC VALVE STENOSIS 1 0.0006
188 CHEILITIS 3 0.0006
189 TIC 3 0.0005
190 NONSPECIFIC REACTION 3 0.0005
191 FOOD INTOLERANCE 2 0.0005
192 GASTROINTESTINAL PAIN 6 0.0005
193 SEBORRHOEA 2 0.0005
194 CHOKING SENSATION 3 0.0005
195 WOUND HAEMORRHAGE 2 0.0005
196 INTERVERTEBRAL DISC DEGENERATION 5 0.0005
197 STREPTOCOCCAL INFECTION 3 0.0005
198 ACCIDENTAL DEATH 1 0.0005
199 HYPERACUSIS 2 0.0005
200 MACULAR OEDEMA 3 0.0005
201 HEART RATE IRREGULAR 12 0.0005
202 MITRAL VALVE INCOMPETENCE 6 0.0005
203 GRANULOCYTOPENIA 3 0.0005
204 SKIN EXFOLIATION 44 0.0005
205 GINGIVAL DISORDER 2 0.0005
206 OESOPHAGEAL DISORDER 2 0.0005
207 URINE ODOUR ABNORMAL 3 0.0005
208 THERAPY CHANGE 5 0.0005
209 SKIN ODOUR ABNORMAL 2 0.0005
210 FURUNCLE 4 0.0005
211 PATENT DUCTUS ARTERIOSUS 2 0.0005
212 RENAL CYST 4 0.0005
213 HYPERPHAGIA 2 0.0005
214 SKIN PAPILLOMA 2 0.0005
215 BLOOD PRESSURE INADEQUATELY CONTROLLED 3 0.0005
216 INTRACRANIAL ANEURYSM 2 0.0005
217 NOCTURIA 6 0.0005
218 APPLICATION SITE DISCOLOURATION 2 0.0005
219 VULVOVAGINAL BURNING SENSATION 3 0.0005
220 TRIGGER FINGER 2 0.0005
221 DRUG ADMINISTRATION ERROR 15 0.0005
222 INITIAL INSOMNIA 5 0.0005
223 HAIR DISORDER 4 0.0005
224 ACCIDENTAL EXPOSURE 2 0.0005
225 SWOLLEN TONGUE 15 0.0005
226 CONGESTIVE CARDIOMYOPATHY 2 0.0005
227 PRODUCT QUALITY ISSUE 65 0.0005
228 CHRONIC KIDNEY DISEASE 36 0.0005
229 GASTRIC ULCER 9 0.0005
230 MUSCLE FATIGUE 2 0.0005
231 POOR PERIPHERAL CIRCULATION 2 0.0005
232 IMPAIRED WORK ABILITY 10 0.0005
233 SCAR 8 0.0005
234 MUSCLE STRAIN 4 0.0005
235 HERPES SIMPLEX 3 0.0005
236 CHAPPED LIPS 2 0.0005
237 LOCAL SWELLING 8 0.0005
238 POLYP 3 0.0005
239 DIVERTICULUM INTESTINAL 2 0.0005
240 WALKING AID USER 3 0.0005
241 LUNG INFILTRATION 4 0.0005
242 GINGIVAL SWELLING 2 0.0005
243 TENDONITIS 7 0.0005
244 NERVE INJURY 5 0.0004
245 ILEUS PARALYTIC 2 0.0004
246 ABASIA 11 0.0004
247 DRUG EXPOSURE DURING PREGNANCY 15 0.0004
248 AGEUSIA 11 0.0004
249 CRYING 16 0.0004
250 URINARY INCONTINENCE 13 0.0004
251 ECCHYMOSIS 3 0.0004
252 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 31 0.0004
253 APHTHOUS STOMATITIS 1 0.0004
254 MADAROSIS 5 0.0004
255 EYELID OEDEMA 5 0.0004
256 DEFAECATION URGENCY 3 0.0004
257 SKIN TIGHTNESS 2 0.0004
258 DIVERTICULUM 3 0.0004
259 BLOOD IRON DECREASED 5 0.0004
260 WRIST FRACTURE 5 0.0004
261 PANIC REACTION 3 0.0004
262 VULVOVAGINAL PAIN 2 0.0004
263 TONGUE DISORDER 3 0.0004
264 HAEMORRHOIDAL HAEMORRHAGE 2 0.0004
265 INFLAMMATORY BOWEL DISEASE 4 0.0004
266 SPRUE-LIKE ENTEROPATHY 2 0.0004
267 EXPIRED DRUG ADMINISTERED 2 0.0004
268 ACTIVITIES OF DAILY LIVING IMPAIRED 8 0.0004
269 HAEMATOCRIT DECREASED 8 0.0004
270 HAIR COLOUR CHANGES 5 0.0004
271 RASH PAPULAR 9 0.0004
272 MUSCULOSKELETAL PAIN 21 0.0004
273 VEIN DISORDER 2 0.0004
274 GASTROOESOPHAGEAL REFLUX DISEASE 32 0.0004
275 DRY THROAT 4 0.0004
276 INCREASED UPPER AIRWAY SECRETION 2 0.0004
277 DRY SKIN 52 0.0004
278 PERICARDIAL EFFUSION 9 0.0004
279 THYROID DISORDER 6 0.0004
280 PAIN IN JAW 11 0.0004
281 FLATULENCE 22 0.0004
282 TRISMUS 2 0.0004
283 APNOEA 3 0.0004
284 VENTRICULAR EXTRASYSTOLES 4 0.0004
285 BONE DISORDER 7 0.0004
286 END STAGE RENAL DISEASE 7 0.0004
287 AFFECTIVE DISORDER 3 0.0004
288 PULMONARY CONGESTION 5 0.0004
289 BLOOD ALBUMIN DECREASED 3 0.0004
290 DYSPHONIA 22 0.0004
291 DYSPEPSIA 37 0.0004
292 MIDDLE INSOMNIA 7 0.0004
293 TUBULOINTERSTITIAL NEPHRITIS 7 0.0004
294 SENSORY LOSS 3 0.0004
295 POOR QUALITY SLEEP 8 0.0004
296 STRESS FRACTURE 2 0.0004
297 BLOOD URINE PRESENT 7 0.0004
298 SLEEP APNOEA SYNDROME 7 0.0004
299 INCREASED APPETITE 7 0.0004
300 INTERVERTEBRAL DISC PROTRUSION 8 0.0004
301 PRODUCT SUBSTITUTION ISSUE 21 0.0004
302 PERIPHERAL COLDNESS 5 0.0004
303 ASTHENOPIA 2 0.0004
304 INJECTION SITE NODULE 4 0.0004
305 PROSTATIC SPECIFIC ANTIGEN INCREASED 5 0.0004
306 DEAFNESS UNILATERAL 2 0.0004
307 PROSTATIC DISORDER 2 0.0004
308 ORAL DISCOMFORT 5 0.0004
309 FEELING COLD 10 0.0004
310 HEART RATE ABNORMAL 2 0.0004
311 ATRIAL SEPTAL DEFECT 3 0.0004
312 ANGER 12 0.0004
313 IMPAIRED DRIVING ABILITY 4 0.0004
314 PRODUCT CONTAINER ISSUE 3 0.0003
315 CARDIAC VALVE DISEASE 2 0.0003
316 VENTRICULAR SEPTAL DEFECT 2 0.0003
317 SKIN HYPERPIGMENTATION 3 0.0003
318 HYPERVENTILATION 2 0.0003
319 CAESAREAN SECTION 4 0.0003
320 NAIL DISORDER 3 0.0003
321 BLOOD CALCIUM INCREASED 3 0.0003
322 GROIN PAIN 3 0.0003
323 SPINAL OSTEOARTHRITIS 3 0.0003
324 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
325 ENERGY INCREASED 2 0.0003
326 CARDIOMYOPATHY 5 0.0003
327 OCULAR HYPERAEMIA 16 0.0003
328 PLEURISY 2 0.0003
329 WRONG DRUG ADMINISTERED 3 0.0003
330 FACIAL PAIN 3 0.0003
331 CARDIAC PACEMAKER INSERTION 2 0.0003
332 ODYNOPHAGIA 2 0.0003
333 INTENTIONAL DRUG MISUSE 7 0.0003
334 DRUG EFFECT DECREASED 18 0.0003
335 TYPE 1 DIABETES MELLITUS 2 0.0003
336 ACNE CYSTIC 1 0.0003
337 ERYTHEMA 68 0.0003
338 LIP DRY 3 0.0003
339 ECONOMIC PROBLEM 5 0.0003
340 OSTEOPENIA 5 0.0003
341 MYALGIA 56 0.0003
342 HIDRADENITIS 3 0.0003
343 SKIN DISCOLOURATION 15 0.0003
344 DYSURIA 12 0.0003
345 NERVOUSNESS 17 0.0003
346 GRAND MAL CONVULSION 3 0.0003
347 PRURITUS GENERALISED 7 0.0003
348 THINKING ABNORMAL 6 0.0003
349 LUNG INFECTION 5 0.0003
350 ERYTHEMA MULTIFORME 3 0.0003
351 ALOPECIA 63 0.0003
352 INJECTION SITE DISCOLOURATION 4 0.0003
353 ABORTION INDUCED 3 0.0003
354 ABDOMINAL ADHESIONS 1 0.0003
355 RASH MACULAR 11 0.0003
356 FOREIGN BODY SENSATION IN EYES 2 0.0003
357 DRUG PRESCRIBING ERROR 6 0.0003
358 THERAPEUTIC RESPONSE UNEXPECTED 14 0.0003
359 MOVEMENT DISORDER 10 0.0003
360 FEELING HOT 19 0.0003
361 CARDIAC FLUTTER 2 0.0003
362 INCOHERENT 2 0.0003
363 RASH GENERALISED 8 0.0003
364 MUSCLE TIGHTNESS 5 0.0003
365 CHOKING 6 0.0003
366 BACK DISORDER 5 0.0003
367 BRADYPHRENIA 2 0.0003
368 RENAL TUBULAR NECROSIS 3 0.0003
369 GASTRITIS 8 0.0003
370 RENAL INJURY 9 0.0003
371 PREGNANCY 6 0.0003
372 JOINT RANGE OF MOTION DECREASED 4 0.0003
373 FEAR 8 0.0003
374 VAGINAL DISCHARGE 3 0.0003
375 DRUG DOSE OMISSION 49 0.0003
376 POSTOPERATIVE WOUND INFECTION 2 0.0003
377 ULCER HAEMORRHAGE 2 0.0003
378 FLUSHING 30 0.0003
379 MOTOR DYSFUNCTION 3 0.0003
380 SLUGGISHNESS 3 0.0003
381 HEART RATE INCREASED 29 0.0003
382 ARTHRITIS 23 0.0003
383 EAR DISCOMFORT 3 0.0003
384 RESPIRATION ABNORMAL 2 0.0003
385 THROAT IRRITATION 13 0.0003
386 EYE DISCHARGE 3 0.0003
387 LARGE INTESTINE POLYP 2 0.0003
388 PRESYNCOPE 7 0.0003
389 WEIGHT FLUCTUATION 3 0.0003
390 PRODUCT ODOUR ABNORMAL 3 0.0003
391 INCONTINENCE 3 0.0003
392 BLINDNESS UNILATERAL 4 0.0003
393 DUODENAL ULCER 2 0.0003
394 RENAL PAIN 3 0.0003
395 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
396 HAND FRACTURE 2 0.0003
397 THERMAL BURN 2 0.0003
398 BREAST PAIN 3 0.0003
399 CONTUSION 27 0.0003
400 THIRST 5 0.0003
401 RED BLOOD CELL COUNT DECREASED 8 0.0003
402 CONVULSION 16 0.0003
403 OEDEMA PERIPHERAL 34 0.0003
404 GOUT 5 0.0003
405 APPARENT DEATH 1 0.0003
406 MENSTRUATION DELAYED 3 0.0003
407 VISUAL FIELD DEFECT 2 0.0003
408 FAECES DISCOLOURED 6 0.0003
409 SWELLING FACE 18 0.0003
410 PERITONEAL DIALYSIS COMPLICATION 2 0.0003
411 BLOOD GLUCOSE FLUCTUATION 3 0.0003
412 MAJOR DEPRESSION 2 0.0003
413 CHEST DISCOMFORT 28 0.0003
414 BLINDNESS TRANSIENT 2 0.0003
415 RED BLOOD CELL SEDIMENTATION RATE INCREASED 3 0.0003
416 PSYCHIATRIC SYMPTOM 2 0.0003
417 CEREBRAL DISORDER 2 0.0003
418 MEDICATION ERROR 15 0.0003
419 DIPLOPIA 7 0.0003
420 NECK PAIN 15 0.0003
421 BREAST TENDERNESS 2 0.0003
422 HYPOAESTHESIA ORAL 4 0.0003
423 JOINT SWELLING 32 0.0003
424 PAROSMIA 2 0.0003
425 MUSCULAR WEAKNESS 30 0.0003
426 FOOT FRACTURE 5 0.0003
427 FEELING ABNORMAL 63 0.0003
428 MICTURITION URGENCY 3 0.0003
429 FEELING JITTERY 5 0.0003
430 MATERNAL DRUGS AFFECTING FOETUS 2 0.0003
431 PARAESTHESIA 41 0.0003
432 GLAUCOMA 5 0.0003
433 ANKLE FRACTURE 4 0.0003
434 LIMB INJURY 7 0.0003
435 EJECTION FRACTION DECREASED 4 0.0003
436 HEART RATE DECREASED 9 0.0003
437 RECTAL HAEMORRHAGE 11 0.0003
438 GAIT DISTURBANCE 49 0.0003
439 TREATMENT NONCOMPLIANCE 14 0.0003
440 MULTIPLE ALLERGIES 2 0.0003
441 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
442 DYSPHAGIA 24 0.0003
443 SINUS DISORDER 5 0.0003
444 TRICUSPID VALVE INCOMPETENCE 2 0.0003
445 INJECTION SITE HAEMORRHAGE 20 0.0003
446 DIZZINESS 124 0.0002
447 NIGHT SWEATS 8 0.0002
448 RHINITIS 2 0.0002
449 THERAPEUTIC RESPONSE DECREASED 15 0.0002
450 MUSCLE DISORDER 2 0.0002
451 AMNESIA 16 0.0002
452 HYPERAESTHESIA 2 0.0002
453 OSTEOPOROSIS 10 0.0002
454 APPLICATION SITE EXFOLIATION 1 0.0002
455 PHOTOSENSITIVITY REACTION 4 0.0002
456 DEVICE MALFUNCTION 17 0.0002
457 SPINAL COMPRESSION FRACTURE 2 0.0002
458 MUSCLE INJURY 2 0.0002
459 DISTURBANCE IN ATTENTION 13 0.0002
460 EXPIRED PRODUCT ADMINISTERED 8 0.0002
461 DRY EYE 12 0.0002
462 FUNGAL INFECTION 8 0.0002
463 RASH PRURITIC 13 0.0002
464 TINNITUS 11 0.0002
465 BONE PAIN 14 0.0002
466 OROPHARYNGEAL PAIN 22 0.0002
467 ASTHENIA 89 0.0002
468 BLOOD CHOLESTEROL INCREASED 11 0.0002
469 OSTEOARTHRITIS 10 0.0002
470 EATING DISORDER 5 0.0002
471 INTRAOCULAR PRESSURE INCREASED 3 0.0002
472 RETCHING 5 0.0002
473 MUSCLE SPASMS 43 0.0002
474 DRY MOUTH 19 0.0002
475 HYPOAESTHESIA 35 0.0002
476 ERECTILE DYSFUNCTION 6 0.0002
477 IRRITABILITY 14 0.0002
478 CHEST PAIN 43 0.0002
479 PARANOIA 4 0.0002
480 BLOOD MAGNESIUM DECREASED 2 0.0002
481 LACRIMATION INCREASED 7 0.0002
482 DYSPNOEA 131 0.0002
483 INJECTION SITE INDURATION 3 0.0002
484 CARDIAC MURMUR 2 0.0002
485 PLATELET COUNT INCREASED 3 0.0002
486 SPEECH DISORDER 12 0.0002
487 BLOOD PRESSURE INCREASED 35 0.0002
488 DYSGEUSIA 17 0.0002
489 URINE OUTPUT DECREASED 2 0.0002
490 BACK PAIN 53 0.0002
491 IMMUNE SYSTEM DISORDER 3 0.0002
492 TOOTH INFECTION 3 0.0002
493 EMOTIONAL DISORDER 7 0.0002
494 APPLICATION SITE PAIN 5 0.0002
495 ABDOMINAL ABSCESS 1 0.0002
496 LIMB DISCOMFORT 7 0.0002
497 PURPURA 2 0.0002
498 LYMPHADENOPATHY 8 0.0002
499 ATRIAL FIBRILLATION 22 0.0002
500 VISION BLURRED 31 0.0002
501 BLOOD PRESSURE DECREASED 15 0.0002
502 MALIGNANT MELANOMA 3 0.0002
503 QUALITY OF LIFE DECREASED 3 0.0002
504 INSOMNIA 59 0.0002
505 CHROMATURIA 5 0.0002
506 TOOTHACHE 4 0.0002
507 DRUG TOXICITY 3 0.0002
508 BALANCE DISORDER 19 0.0002
509 DEPRESSION 50 0.0002
510 PANIC ATTACK 8 0.0002
511 ABDOMINAL HERNIA 1 0.0002
512 CORONARY ARTERY OCCLUSION 3 0.0002
513 INFLUENZA LIKE ILLNESS 18 0.0002
514 HIP FRACTURE 7 0.0002
515 INCREASED TENDENCY TO BRUISE 2 0.0002
516 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
517 PAIN IN EXTREMITY 64 0.0002
518 MUSCLE TWITCHING 5 0.0002
519 TREMOR 36 0.0002
520 NERVE COMPRESSION 2 0.0002
521 BLOOD GLUCOSE ABNORMAL 4 0.0002
522 EYE SWELLING 8 0.0002
523 CARPAL TUNNEL SYNDROME 3 0.0002
524 BURNING SENSATION 15 0.0002
525 SKIN REACTION 3 0.0002
526 PHOTOPHOBIA 4 0.0002
527 LACERATION 2 0.0002
528 ARRHYTHMIA 10 0.0002
529 SPUTUM DISCOLOURED 2 0.0002
530 PRODUCT PACKAGING ISSUE 2 0.0002
531 NEUROPATHY PERIPHERAL 20 0.0002
532 SKIN DISORDER 7 0.0002
533 RECALLED PRODUCT ADMINISTERED 2 0.0002
534 PRODUCTIVE COUGH 10 0.0002
535 EYE IRRITATION 12 0.0002
536 BLOOD GLUCOSE DECREASED 10 0.0002
537 PARAESTHESIA ORAL 3 0.0002
538 AFFECT LABILITY 2 0.0002
539 APHAGIA 1 0.0002
540 HYPERTHYROIDISM 3 0.0002
541 ATELECTASIS 2 0.0002
542 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
543 LIVER FUNCTION TEST ABNORMAL 6 0.0002
544 EAR PAIN 4 0.0002
545 WEIGHT INCREASED 46 0.0002
546 VITAMIN D DEFICIENCY 2 0.0002
547 PALPITATIONS 24 0.0002
548 HYPERSENSITIVITY 38 0.0002
549 SURGERY 12 0.0002
550 WEIGHT DECREASED 57 0.0002
551 HEPATOMEGALY 2 0.0002
552 APPLICATION SITE BURN 1 0.0002
553 LIGAMENT SPRAIN 2 0.0002
554 CATARACT 12 0.0002
555 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
556 APPLICATION SITE SWELLING 1 0.0002
557 OVARIAN CYST 2 0.0002
558 BLOOD POTASSIUM DECREASED 6 0.0002
559 APHASIA 6 0.0002
560 SOMNOLENCE 40 0.0002
561 SLEEP DISORDER 14 0.0002
562 ABDOMINAL PAIN LOWER 5 0.0002
563 CONSTIPATION 43 0.0002
564 TASTE DISORDER 4 0.0002
565 BONE MARROW FAILURE 4 0.0002
566 DRUG DISPENSING ERROR 3 0.0002
567 COUGH 55 0.0002
568 RENAL FAILURE 26 0.0002
569 LOSS OF CONSCIOUSNESS 25 0.0002
570 PHARYNGEAL OEDEMA 3 0.0002
571 INJECTION SITE WARMTH 4 0.0002
572 ABDOMINAL PAIN UPPER 40 0.0002
573 LYMPHOMA 3 0.0002
574 MUSCULOSKELETAL STIFFNESS 17 0.0002
575 ANAEMIA 37 0.0002
576 MUSCULOSKELETAL CHEST PAIN 3 0.0002
577 SKIN ULCER 5 0.0002
578 PRURITUS 74 0.0002
579 BONE DENSITY DECREASED 6 0.0002
580 ROAD TRAFFIC ACCIDENT 8 0.0002
581 JOINT STIFFNESS 5 0.0002
582 HEADACHE 119 0.0002
583 DRUG ADMINISTERED AT INAPPROPRIATE SITE 2 0.0002
584 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
585 JOINT DISLOCATION 2 0.0002
586 ABDOMINAL PAIN 44 0.0002
587 RESPIRATORY TRACT CONGESTION 3 0.0002
588 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
589 SCIATICA 3 0.0002
590 ANORECTAL DISCOMFORT 1 0.0002
591 HYPOTHYROIDISM 6 0.0002
592 ARTHRALGIA 78 0.0002
593 ANAL FISTULA 1 0.0002
594 EPISTAXIS 14 0.0002
595 MENSTRUATION IRREGULAR 5 0.0002
596 HYPERHIDROSIS 24 0.0002
597 FATIGUE 145 0.0002
598 ANAL ABSCESS 1 0.0002
599 HAEMOGLOBIN DECREASED 19 0.0002
600 THROAT TIGHTNESS 5 0.0002
601 PHARYNGITIS STREPTOCOCCAL 2 0.0002
602 DEVICE LEAKAGE 8 0.0002
603 VAGINAL HAEMORRHAGE 8 0.0002
604 SKIN LACERATION 2 0.0002
605 MENTAL DISORDER 8 0.0002
606 PULMONARY THROMBOSIS 2 0.0002
607 MOOD ALTERED 5 0.0002
608 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
609 MULTIPLE FRACTURES 3 0.0002
610 MANIA 3 0.0002
611 ABDOMINAL DISTENSION 19 0.0002
612 TOOTH FRACTURE 2 0.0002
613 RASH 79 0.0002
614 RESPIRATORY DISTRESS 5 0.0002
615 INFUSION RELATED REACTION 12 0.0002
616 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
617 VERTIGO 11 0.0002
618 VENTRICULAR FIBRILLATION 2 0.0002
619 COAGULOPATHY 3 0.0002
620 URINARY RETENTION 6 0.0002
621 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
622 URTICARIA 30 0.0002
623 ABDOMINAL DISCOMFORT 30 0.0002
624 MALNUTRITION 2 0.0002
625 PULMONARY OEDEMA 8 0.0002
626 ORAL PAIN 4 0.0002
627 CELLULITIS 9 0.0002
628 OCULAR DISCOMFORT 2 0.0002
629 UNDERDOSE 13 0.0002
630 BLOOD CALCIUM DECREASED 2 0.0002
631 CANDIDA INFECTION 3 0.0002
632 EYE PAIN 10 0.0002
633 HEMIPARESIS 3 0.0002
634 METRORRHAGIA 3 0.0002
635 MYOCARDIAL ISCHAEMIA 2 0.0002
636 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
637 CHOLECYSTECTOMY 2 0.0002
638 SUICIDAL IDEATION 16 0.0002
639 MUSCULOSKELETAL DISCOMFORT 3 0.0002
640 HERPES ZOSTER 10 0.0002
641 NEOPLASM 2 0.0002
642 NIGHTMARE 6 0.0002
643 HALLUCINATION 13 0.0002
644 HOT FLUSH 13 0.0002
645 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
646 DYSKINESIA 7 0.0002
647 ANXIETY 49 0.0002
648 RENAL DISORDER 8 0.0002
649 INTENTIONAL PRODUCT MISUSE 15 0.0002
650 NAUSEA 135 0.0002
651 COLD SWEAT 3 0.0002
652 BLOOD GLUCOSE INCREASED 32 0.0002
653 DRUG ERUPTION 3 0.0002
654 WHEEZING 10 0.0002
655 INCORRECT ROUTE OF DRUG ADMINISTRATION 6 0.0002
656 POLLAKIURIA 7 0.0002
657 MACULAR DEGENERATION 2 0.0002
658 HYPERLIPIDAEMIA 2 0.0002
659 MULTIPLE SCLEROSIS 8 0.0002
660 MENTAL IMPAIRMENT 4 0.0002
661 RESTLESS LEGS SYNDROME 3 0.0002
662 BURSITIS 2 0.0002
663 ACCIDENTAL OVERDOSE 6 0.0002
664 LUNG DISORDER 8 0.0002
665 HAEMATOCHEZIA 9 0.0002
666 SMALL INTESTINAL OBSTRUCTION 2 0.0002
667 INJECTION SITE MASS 6 0.0002
668 INJECTION SITE EXTRAVASATION 2 0.0002
669 ARTHROPATHY 9 0.0002
670 FEMUR FRACTURE 5 0.0002
671 HEPATIC ENZYME INCREASED 11 0.0002
672 CYST 2 0.0002
673 ILEUS 2 0.0002
674 EXPOSURE DURING PREGNANCY 10 0.0002
675 HYPERTENSION 34 0.0002
676 PNEUMONIA ASPIRATION 4 0.0002
677 HEPATIC CIRRHOSIS 3 0.0002
678 BLOOD SODIUM DECREASED 3 0.0002
679 DIARRHOEA 102 0.0002
680 INJECTION SITE IRRITATION 2 0.0002
681 CYSTITIS 5 0.0002
682 LETHARGY 9 0.0002
683 GASTROINTESTINAL HAEMORRHAGE 13 0.0002
684 HAEMORRHOIDS 3 0.0002
685 SKIN FISSURES 3 0.0002
686 FALL 51 0.0002
687 NASAL CONGESTION 9 0.0002
688 MENORRHAGIA 3 0.0002
689 NEPHROLITHIASIS 7 0.0002
690 EYE DISORDER 5 0.0002
691 STAPHYLOCOCCAL INFECTION 5 0.0002
692 UPPER RESPIRATORY TRACT INFECTION 7 0.0002
693 ABNORMAL BEHAVIOUR 6 0.0002
694 DYSMENORRHOEA 2 0.0002
695 ADVERSE REACTION 2 0.0002
696 EAR INFECTION 4 0.0002
697 LIP SWELLING 5 0.0001
698 PLATELET COUNT DECREASED 16 0.0001
699 SWELLING 14 0.0001
700 DRUG INEFFECTIVE 196 0.0001
701 PRODUCT PHYSICAL ISSUE 3 0.0001
702 JAUNDICE 4 0.0001
703 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
704 ILL-DEFINED DISORDER 9 0.0001
705 DRUG WITHDRAWAL SYNDROME 13 0.0001
706 BLOOD BILIRUBIN INCREASED 4 0.0001
707 FOETAL EXPOSURE DURING PREGNANCY 12 0.0001
708 BODY TEMPERATURE INCREASED 3 0.0001
709 IMPAIRED GASTRIC EMPTYING 2 0.0001
710 GINGIVAL BLEEDING 2 0.0001
711 RASH ERYTHEMATOUS 7 0.0001
712 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7 0.0001
713 GASTRIC DISORDER 5 0.0001
714 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
715 APPLICATION SITE RASH 2 0.0001
716 CARDIAC ARREST 12 0.0001
717 ABNORMAL DREAMS 4 0.0001
718 PERITONITIS 3 0.0001
719 TOOTH LOSS 3 0.0001
720 VOMITING 68 0.0001
721 HUNGER 2 0.0001
722 DERMATITIS 3 0.0001
723 KNEE ARTHROPLASTY 3 0.0001
724 BLISTER 8 0.0001
725 MOUTH ULCERATION 3 0.0001
726 BLOOD TEST ABNORMAL 2 0.0001
727 CONFUSIONAL STATE 23 0.0001
728 INCORRECT DRUG ADMINISTRATION DURATION 4 0.0001
729 PAIN 87 0.0001
730 RENAL FAILURE ACUTE 6 0.0001
731 SINUS TACHYCARDIA 2 0.0001
732 JOINT INJURY 3 0.0001
733 IRRITABLE BOWEL SYNDROME 3 0.0001
734 AGGRESSION 7 0.0001
735 CEREBRAL HAEMORRHAGE 5 0.0001
736 HYPERSOMNIA 4 0.0001
737 SKIN CANCER 3 0.0001
738 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
739 PRODUCT USE ISSUE 26 0.0001
740 ANOSMIA 2 0.0001
741 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
742 INJECTION SITE HAEMATOMA 2 0.0001
743 ACUTE KIDNEY INJURY 21 0.0001
744 GASTROENTERITIS 2 0.0001
745 DYSSTASIA 4 0.0001
746 CARDIAC FAILURE CONGESTIVE 11 0.0001
747 THROMBOSIS 11 0.0001
748 RESTLESSNESS 5 0.0001
749 CHILLS 16 0.0001
750 MELAENA 3 0.0001
751 AGITATION 10 0.0001
752 STEVENS-JOHNSON SYNDROME 3 0.0001
753 TRANSAMINASES INCREASED 3 0.0001
754 TOOTH DISORDER 3 0.0001
755 MALAISE 59 0.0001
756 INJECTION SITE PRURITUS 9 0.0001
757 HAEMORRHAGE 14 0.0001
758 SNEEZING 3 0.0001
759 RESPIRATORY DISORDER 4 0.0001
760 ASTHMA 15 0.0001
761 DEPRESSED MOOD 7 0.0001
762 CORONARY ARTERY DISEASE 4 0.0001
763 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
764 PLEURAL EFFUSION 8 0.0001
765 AORTIC ANEURYSM 1 0.0001
766 ACIDOSIS 1 0.0001
767 HIP ARTHROPLASTY 2 0.0001
768 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
769 NASOPHARYNGITIS 24 0.0001
770 SYNCOPE 13 0.0001
771 HYPOTENSION 26 0.0001
772 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
773 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 6 0.0001
774 BASAL CELL CARCINOMA 2 0.0001
775 INJURY 9 0.0001
776 PRODUCT USE COMPLAINT 2 0.0001
777 HEAD INJURY 4 0.0001
778 PNEUMOTHORAX 2 0.0001
779 PREMATURE DELIVERY 2 0.0001
780 MOBILITY DECREASED 9 0.0001
781 DECREASED APPETITE 29 0.0001
782 SENSORY DISTURBANCE 2 0.0001
783 LOCALISED INFECTION 3 0.0001
784 RHINORRHOEA 8 0.0001
785 HYPOGLYCAEMIA 6 0.0001
786 FIBROMYALGIA 3 0.0001
787 BLOOD POTASSIUM INCREASED 2 0.0001
788 CEREBRAL INFARCTION 3 0.0001
789 BLINDNESS 5 0.0001
790 INCORRECT DOSE ADMINISTERED 28 0.0001
791 ABNORMAL FAECES 1 0.0001
792 IMPAIRED HEALING 4 0.0001
793 VENTRICULAR TACHYCARDIA 2 0.0001
794 DRUG LEVEL INCREASED 2 0.0001
795 ACUTE CORONARY SYNDROME 1 0.0001
796 VISUAL ACUITY REDUCED 4 0.0001
797 WHITE BLOOD CELL COUNT DECREASED 13 0.0001
798 BLOOD UREA INCREASED 2 0.0001
799 ADVERSE EVENT 11 0.0001
800 WITHDRAWAL SYNDROME 5 0.0001
801 CEREBROVASCULAR ACCIDENT 20 0.0001
802 FLUID RETENTION 6 0.0001
803 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
804 PNEUMONIA 38 0.0001
805 HYPOPHAGIA 3 0.0001
806 THERAPY CESSATION 6 0.0001
807 PERIPHERAL SWELLING 18 0.0001
808 ANURIA 1 0.0001
809 MIGRAINE 11 0.0001
810 MYOCARDIAL INFARCTION 20 0.0001
811 APPLICATION SITE ERYTHEMA 3 0.0001
812 NEUROTOXICITY 2 0.0001
813 ALANINE AMINOTRANSFERASE INCREASED 7 0.0001
814 ANGIOEDEMA 5 0.0001
815 HEAD DISCOMFORT 2 0.0001
816 ASPARTATE AMINOTRANSFERASE INCREASED 6 0.0001
817 INJECTION SITE ERYTHEMA 14 0.0001
818 INJECTION SITE BRUISING 9 0.0001
819 ISCHAEMIC STROKE 2 0.0001
820 GALLBLADDER DISORDER 2 0.0001
821 OVERDOSE 24 0.0001
822 FREQUENT BOWEL MOVEMENTS 3 0.0001
823 SYNOVITIS 2 0.0001
824 GASTROENTERITIS VIRAL 2 0.0001
825 LEUKOCYTOSIS 2 0.0001
826 DRUG EFFECT INCOMPLETE 4 0.0001
827 SKIN LESION 3 0.0001
828 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
829 DIVERTICULITIS 3 0.0001
830 CONJUNCTIVITIS 2 0.0001
831 HEPATIC STEATOSIS 2 0.0001
832 SINUSITIS 11 0.0001
833 DRUG INTERACTION 17 0.0001
834 COGNITIVE DISORDER 5 0.0001
835 APPENDICITIS 1 0.0001
836 OXYGEN SATURATION DECREASED 6 0.0001
837 DYSARTHRIA 4 0.0001
838 FRACTURE 2 0.0001
839 COLITIS 4 0.0001
840 MUSCULOSKELETAL DISORDER 2 0.0001
841 DEHYDRATION 14 0.0001
842 ANGINA PECTORIS 3 0.0001
843 POST PROCEDURAL COMPLICATION 2 0.0001
844 LOWER LIMB FRACTURE 2 0.0001
845 PYREXIA 36 0.0001
846 DYSTONIA 2 0.0001
847 KIDNEY INFECTION 2 0.0001
848 ACUTE MYOCARDIAL INFARCTION 3 0.0001
849 LABORATORY TEST ABNORMAL 3 0.0001
850 PSYCHOTIC DISORDER 3 0.0001
851 DISABILITY 2 0.0001
852 DISORIENTATION 4 0.0001
853 UPPER LIMB FRACTURE 2 0.0001
854 PRESCRIBED UNDERDOSE 2 0.0001
855 ADVERSE DRUG REACTION 9 0.0001
856 ABORTION SPONTANEOUS 4 0.0001
857 SPINAL FRACTURE 2 0.0001
858 URINARY TRACT INFECTION 17 0.0001
859 HEPATIC FAILURE 3 0.0001
860 STOMATITIS 6 0.0001
861 INJURY ASSOCIATED WITH DEVICE 2 0.0001
862 INFLAMMATION 5 0.0001
863 PULMONARY HYPERTENSION 2 0.0001
864 RENAL IMPAIRMENT 8 0.0001
865 HALLUCINATION, VISUAL 2 0.0001
866 PULMONARY EMBOLISM 9 0.0001
867 PANCREATITIS 5 0.0001
868 MOOD SWINGS 3 0.0001
869 DEEP VEIN THROMBOSIS 6 0.0001
870 PRODUCT DOSE OMISSION 6 0.0001
871 BLOOD CREATININE INCREASED 6 0.0001
872 CHOLELITHIASIS 3 0.0001
873 VIRAL INFECTION 3 0.0001
874 PANCYTOPENIA 5 0.0001
875 GLOSSODYNIA 2 0.0001
876 GASTROINTESTINAL DISORDER 8 0.0001
877 PANCREATITIS ACUTE 2 0.0001
878 CONDITION AGGRAVATED 27 0.0001
879 NEUTROPENIA 12 0.0001
880 APPLICATION SITE PRURITUS 2 0.0001
881 RHEUMATOID ARTHRITIS 10 0.0001
882 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
883 HYPERKALAEMIA 3 0.0001
884 DRUG INTOLERANCE 8 0.0001
885 HYPERGLYCAEMIA 3 0.0001
886 RESPIRATORY FAILURE 6 0.0001
887 DISCOMFORT 5 0.0001
888 INJECTION SITE URTICARIA 2 0.0001
889 LIVER INJURY 2 0.0001
890 ENCEPHALOPATHY 2 0.0001
891 INFLUENZA 9 0.0001
892 APPLICATION SITE IRRITATION 1 0.0001
893 MEMORY IMPAIRMENT 11 0.0001
894 DYSPNOEA EXERTIONAL 3 0.0001
895 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
896 PRODUCT COMPLAINT 2 0.0001
897 HAEMATEMESIS 2 0.0001
898 DIABETES MELLITUS 6 0.0001
899 MATERNAL EXPOSURE DURING PREGNANCY 7 0.0001
900 INJECTION SITE SWELLING 6 0.0001
901 INJECTION SITE PAIN 24 0.0001
902 HEPATITIS 2 0.0001
903 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 14 0.0001
904 UNRESPONSIVE TO STIMULI 2 0.0001
905 PSORIASIS 10 0.0001
906 ECZEMA 4 0.0001
907 SEDATION 2 0.0001
908 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
909 ANHEDONIA 2 0.0001
910 BREAST CANCER 7 0.0001
911 OEDEMA 4 0.0001
912 PALLOR 2 0.0001
913 PNEUMONITIS 2 0.0001
914 ACUTE HEPATIC FAILURE 1 0.0001
915 RESPIRATORY ARREST 2 0.0001
916 ANAPHYLACTIC REACTION 4 0.0001
917 MENTAL STATUS CHANGES 2 0.0001
918 HAEMOPTYSIS 2 0.0001
919 TARDIVE DYSKINESIA 2 0.0001
920 HYPOACUSIS 3 0.0001
921 PANCREATIC CARCINOMA 2 0.0001
922 DEVICE DISLOCATION 3 0.0001
923 APATHY 1 0.0001
924 ASCITES 2 0.0001
925 BRONCHITIS 5 0.0001
926 TACHYCARDIA 6 0.0001
927 DEVICE ISSUE 6 0.0001
928 THERAPY NON-RESPONDER 3 0.0001
929 PREMATURE BABY 2 0.0001
930 UNEVALUABLE EVENT 5 0.0001
931 EMOTIONAL DISTRESS 8 0.0001
932 GYNAECOMASTIA 2 0.0001
933 VISUAL IMPAIRMENT 8 0.0001
934 ACUTE MYELOID LEUKAEMIA 1 0.0001
935 CARDIAC DISORDER 6 0.0001
936 NERVOUS SYSTEM DISORDER 2 0.0001
937 COMA 3 0.0001
938 ABSCESS 1 0.0001
939 THROMBOCYTOPENIA 7 0.0001
940 LACTIC ACIDOSIS 2 0.0001
941 LEUKOPENIA 3 0.0001
942 GAIT INABILITY 2 0.0001
943 TYPE 2 DIABETES MELLITUS 2 0.0001
944 HAEMATURIA 2 0.0001
945 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
946 HYPOXIA 2 0.0001
947 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
948 PRODUCT ADHESION ISSUE 2 0.0001
949 INTESTINAL OBSTRUCTION 2 0.0001
950 OFF LABEL USE 46 0.0001
951 ACUTE RESPIRATORY FAILURE 1 0.0001
952 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
953 NO ADVERSE EVENT 9 0.0000
954 LUNG NEOPLASM MALIGNANT 2 0.0000
955 RHABDOMYOLYSIS 2 0.0000
956 CARDIO-RESPIRATORY ARREST 2 0.0000
957 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
958 SEPTIC SHOCK 2 0.0000
959 HOSPITALISATION 7 0.0000
960 FEBRILE NEUTROPENIA 3 0.0000
961 LIVER DISORDER 2 0.0000
962 NEOPLASM MALIGNANT 3 0.0000
963 SEPSIS 5 0.0000
964 COLITIS ULCERATIVE 2 0.0000
965 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
966 HYPOKALAEMIA 2 0.0000
967 SEIZURE 5 0.0000
968 DISEASE PROGRESSION 5 0.0000
969 RENAL CANCER 2 0.0000
970 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 8 0.0000
971 ANAPHYLACTIC SHOCK 1 0.0000
972 BRADYCARDIA 2 0.0000
973 CARDIAC FAILURE 3 0.0000
974 PROSTATE CANCER 3 0.0000
975 SUICIDE ATTEMPT 2 0.0000
976 PRODUCT USE IN UNAPPROVED INDICATION 8 0.0000
977 DEVICE EXPULSION 2 0.0000
978 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
979 INJECTION SITE REACTION 2 0.0000
980 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
981 TOXICITY TO VARIOUS AGENTS 4 0.0000
982 INFECTION 3 0.0000
983 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
984 DRUG DEPENDENCE 3 0.0000
985 DEATH 15 0.0000
986 PRODUCT DOSE OMISSION ISSUE 4 0.0000
987 COVID-19 2 0.0000